Medline Inc.
MDLN | NASDAQ
$32.12
+$0.12 (+0.37%)
At close: Oct 30, 2026, 4:00 PM ET
$32.30
+$0.18 (+0.56%)
Pre-market:
Nov 2, 2026, 7:27 AM ET
TTM Period Ending | Q2 2026 Jun 27, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
Revenue | 29.94B | 29.14B | 28.43B | 20.65B | 19.92B | 19.22B | 12.57B | 6.19B |
Cost of Revenue | 22.45B | 22.13B | 21.44B | 15.57B | 14.96B | 14.49B | 9.5B | 4.69B |
Gross Profit | 7.49B | 7.01B | 6.99B | 5.08B | 4.96B | 4.73B | 3.08B | 1.49B |
Operating Income | 1.82B | 2.05B | 2.22B | 1.79B | 1.79B | 1.68B | 1.09B | 516M |
Interest Income | 113M | 94M | 99M | 99M | 137M | 182M | 148M | 75M |
Pretax Income | 1.08B | 1.2B | 1.25B | 1.04B | 1.04B | 976M | 638M | 300M |
Net Income | 691M | 964M | 1.16B | 977M | 979M | 938M | 616M | 292M |
Selling & General & Admin | 4.9B | 4.7B | 4.57B | 3.3B | 3.17B | 3.06B | 1.96B | 976M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 772M | 261M | 204M | -20M | -6M | -18M | 24M | 2M |
Operating Expenses | 5.68B | 4.96B | 4.77B | 3.28B | 3.17B | 3.05B | 1.99B | 978M |
Interest Expense | 727M | 792M | 841M | 675M | 621M | 655M | 441M | 267M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.12B | 27.09B | 26.21B | 18.85B | 18.12B | 17.54B | 11.48B | 5.67B |
Income Tax Expense | 197M | 127M | 91M | 65M | 56M | 38M | 22M | 8M |
Shares Outstanding (Basic) | 857M | 819M | 812M | 787.12M | 787.12M | 799.8M | 787.12M | 787.12M |
Shares Outstanding (Diluted) | 861M | 825M | 812M | 787.12M | 787.12M | 799.8M | 787.12M | 787.12M |
EPS (Basic) | 0.86 | 1.21 | 1.45 | 1.23 | 1.23 | 1.18 | 0.78 | 0.37 |
EPS (Diluted) | 0.86 | 1.21 | 1.45 | 1.23 | 1.23 | 1.18 | 0.78 | 0.37 |
EBITDA | 2.55B | 2.73B | 2.85B | 2.47B | 2.4B | 2.37B | 1.57B | 806M |
EBIT | 1.61B | 1.8B | 1.92B | 1.72B | 1.66B | 1.63B | 1.08B | 567M |
Depreciation & Amortization | 939M | 933M | 926M | 750M | 745M | 734M | 487M | 239M |
Add to Watchlist
Select watchlists to add or remove MDLN